Medicine and Dentistry
Infusion
100%
Antiangiogenic Therapy
100%
Liver Metastasis
100%
Dexamethasone
100%
Common Hepatic Artery
100%
Neoplasm
36%
8 Difluoromethoxy 1 Ethyl 6 Fluoro 1,4 Dihydro 7 [4 (2 Methoxyphenyl) 1 Piperazinyl] 4 Oxo 3 Quinolinecarboxylic Acid
36%
Assay
18%
Growth
18%
Angiogenesis
18%
Malignant Neoplasm
9%
Cancer Cell
9%
Chemotherapy
9%
In Vitro
9%
Antiangiogenic Activity
9%
Chemosensitivity
9%
Arterial Catheter
9%
Colon Cancer
9%
Laparotomy
9%
MTT Assay
9%
Bromide
9%
Floxuridine
9%
Pharmacology, Toxicology and Pharmaceutical Science
Dexamethasone
100%
Liver Metastasis
100%
Antiangiogenic Therapy
100%
Neoplasm
36%
8 Difluoromethoxy 1 Ethyl 6 Fluoro 1,4 Dihydro 7 [4 (2 Methoxyphenyl) 1 Piperazinyl] 4 Oxo 3 Quinolinecarboxylic Acid
36%
Animal
18%
Malignant Neoplasm
9%
Rat
9%
Antiangiogenic
9%
Colon Cancer
9%
Berlin Drucksey IX Rat
9%
Floxuridine
9%
Biochemistry, Genetics and Molecular Biology
Dexamethasone
100%
Growth
18%
Angiogenesis
18%
Cancer Cell
9%
Animal Model
9%
Animal
9%
Rat
9%
Antiangiogenic Activity
9%
MTT Assay
9%
Colon
9%
Bromide
9%
Chemosensitivity
9%
Berlin Drucksey IX Rat
9%
Veterinary Science and Veterinary Medicine